The reduction of browning induced by cachexia has been demonstrated in different studies, through treatment with cyclooxygenase-2 inhibitor (Sulindac), β3-adrenergic receptor antagonist (SR59230A)7 and a knockout model for parathyroid hormone-related protein (PTHrP)38. Here, PTGS2 is linked to Cachexia.